Authors


Steve Davis, MD, DFAPA

Latest:

AMIA 2010

Steve Davis, MD, DFAPA, shares his notes from the annual meeting of the American Medical Informatics Association.


Marie Crandall, MD, MPH

Latest:

Hydatid Liver Disease in a Patient with Chronic Right Upper-Quadrant Abdominal Pain

Hydatid disease of the liver is endemic in some areas of the world but is rarely encountered in the United States. The disease is usually caused by the parasite Echinococcus granulosus. Physicians who work within multicultural communities must be aware of this disease and its treatment. We present the case of a 35-year-old Mexican woman who complained of chronic right upper-quadrant pain. Computed tomography scanning revealed a ring-enhancing lesion within the right lobe of the liver, suggesting the diagnosis of a hydatid cyst. Following a course of antiparasitic therapy, the cyst was surgically removed. Six months later, the patient was pain free.


from the 1department of community and preventive medicine

Latest:

New Framingham Heart Study global cardiovascular risk instruments: Helping physicians optimize their patients' cardiovascular care

While most patients are concerned about their risk for myocardial infarction, it is important to remember that the risk factors for death from all cardiovascular diseases, including stroke, peripheral arterial disease, and coronary artery disease, are similar.


Mary Blanton Wheeler, PharmD, MPH

Latest:

A New Pulmonary Arterial Hypertension Drug on the Horizon

In pulmonary arterial hypertension patients, riociguat serves as a reasonable first-line alternative to PDE-5 inhibitors or in combination therapy with an endothelin antagonist or inhaled prostacyclin analogues.


David R. Grube, MD

Latest:

Ten Facts About Medical Aid in Dying

What a longtime family practitioner in a state that authorizes medical aid in dying has learned through his own experience of the controversial practice.


Keith C. Ferdinand, MD

Latest:

Treatment Decisions and its Relation to Patient Accessibility

Final thoughts from expert KOLs regarding treatment decisions and how they relate to patient accessibility when manage dyslipidemia.


Colleen O'Leary

Latest:

Nurses as Full Partners in Health Care

A recent article outlined the recommendations from the Institute of Medicine that included more training and independence for nurses.



Karl Isaaz, MD: From the Division of Cardiology, University Jean Monnet of Saint-Etienne, Saint-Etienne, France.

Latest:

Should radiofrequency ablation be first-line therapy after a first episode of symptomatic atrial flutter?

Radiofrequency catheter ablation (RFA) is a cost-effective approach that has modified the treatment of patients with supraventricular tachycardia. In the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) study, we compared RFA treatment with amiodarone therapy after the first episode of symptomatic atrial flutter. Results showed that RFA should be considered a first-line treatment, especially in elderly patients, because it has a better long-term success rate, the same risk of subsequent atrial fibrillation as amiodarone, and fewer secondary effects compared with amiodarone. Radiofrequency catheter ablation first-line therapy should be recommended in routine clinical practice, even when the atrial flutter is isolated without a previously documented atrial fibrillation episode.





Wayne Altman, MD

Latest:

Heartache Over New Cholesterol Treatment Guidelines

To produce the greatest impact from the implementation of the new American College of Cardiology and American Heart Association guidelines for the treatment of hypercholesterolemia in the primary prevention of cardiovascular disease (CVD), physicians should counsel patients on the benefits and risks of medication intervention to prevent CVD, but also explain the absolute necessity of regular exercise and abstention from tobacco use.


Dan Theodorescu, MD, PhD

Latest:

Can New Technologies Be Used to Predict Treatment Response in Cancer Patients?

The next leap forward in cancer treatment will see physicians tailoring treatments based on patients' individualized tumor profiles.





Kausik K. Ray, MD, MRCP: From the Department of Public Health

Latest:

Achieving LDL cholesterol goals in elderly patients with ACS

After an acute coronary syndrome (ACS) event, elderly patients are at greater risk of death and nonfatal coronary events compared with younger patients. Despite this, elderly patients continue to receive less evidence-based therapy. Lipidlowering therapy with statins is now routine practice for the secondary prevention of coronary heart disease. Achieving the optional National Cholesterol Expert Panel goal of a low-density lipoprotein cholesterol level of < 70 mg/dL for ACS patients over 70 years of age could prevent nearly 80 deaths or nonfatal coronary events for every 1000 patients treated for 2 years with a number needed to treat of approximately 12.


Frederick A. Spencer, MD3: From the 1Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School,Worce

Latest:

Survival after heart failure

We conducted a multi-hospital population-based study of 2445 residents of a large New England metropolitan area hospitalized with acute heart failure and found that the long-term prognosis for these patients remains poor. More than one third of patients died in the first year after hospital discharge,and nearly 4 of 5 patients died over the 5-year follow-up period. Several demographic and clinical factors were associated with an adverse prognosis. It is important to know the factors that negatively affect long-term survival after hospital discharge for decompensated heart failure so that treatment can be directed toward specific high-risk groups.



Victor Dostrow

Latest:

New Antiepileptic Drugs: A Bit of Bad News

The new generation of AEDs is not perfect. Is anyone surprised by this?


Mark T. Kearney, MD: From the Leeds Institute of Genetics, Health

Latest:

Mortality of patients with diabetes mellitus and acute myocardial infarction

We evaluated trends in the treatment and mortality of patients with and without diabetes mellitus and acute myocardial infarction over the last decade. Despite improvements in the provision of evidence-based care, patients with diabetes did not derive improvements in long-term survival.




Alan S. Brown

Latest:

Hypertriglyceridemia in Connection to FCS

Alan S. Brown, MD, FNLA, FACC, FAHA is a Cardiologist at Advocate Lutheran General Hospital and the President-Elect of the National Lipid Association (NLA). While at the NLA’s 2018 Scientific Sessions in Las Vegas, Nevada, he explained the connection between hypertriglyceridemia and FCS.



Thelma King Thiel

Latest:

Spread the News: Liver Cancer is Preventable

Here's how our understanding of Liver Cancer is changing.


Frank Domino, MD

Latest:

Oral Morphine Versus Ibuprofen to Manage Post-fracture Pain in Children

Is orally administered morphine superior to ibuprofen for outpatient pain management for children with uncomplicated fractures?



© 2024 MJH Life Sciences

All rights reserved.